Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Koji Ohmoto"'
Autor:
Yoshihisa Yamada, Hiroyuki Fujiki, Hiroshi Mizuguchi, Yukinobu Takeshita, Katsuji Hattori, Koji Ohmoto, Miki Aihara, Keisuke Nagano, Yoshimasa Isakari, Miho Yamamoto, Yoshitaka Yamamura
Publikováno v:
Folia Pharmacologica Japonica. 157:254-260
Autor:
Yoshihisa Yamada, Hiroyuki Fujiki, Hiroshi Mizuguchi, Yukinobu Takeshita, Katsuji Hattori, Koji Ohmoto, Miki Aihara, Keisuke Nagano, Yoshimasa Isakar, Miho Yamamoto, Yoshitaka Yamamura
Publikováno v:
Folia Pharmacologica Japonica; 2022, Vol. 157 Issue 4, p254-260, 7p
Autor:
Yukinobu Takeshita, Katsuji Hattori, Keisuke Nagano, Yoshitaka Yamamura, Yoshihisa Yamada, Hiroyuki Fujiki, Hiroshi Mizuguchi, Miki Aihara, Koji Ohmoto
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:1-S11
Autor:
Koji Ohmoto, Yuki Tabata, Toshiaki Kato, Yan Ma, Atsushi Koike, Takayoshi Kuno, Reiko Sugiura, Susie O. Sio
Publikováno v:
Journal of Biological Chemistry. 287:19294-19303
Calcineurin phosphatase plays crucial roles in a wide variety of cell types and organisms. Dephosphorylation of the nuclear factor of activated T-cell (NFAT) family of transcriptional factors by calcineurin is essential for activating immune-responsi
Publikováno v:
Cardiovascular Drugs and Therapy. 25:77-82
The aim of this study was to evaluate the therapeutic efficacy of tolvaptan, a vasopressin V(2) receptor antagonist, on edema in two rat models: 1) histamine-induced vascular hyperpermeability of the dorsal skin and 2) carrageenan-induced paw edema.I
Autor:
Katsuji Hattori, Hiroshi Mizuguchi, Makoto Ishikawa, Hiroyuki Fujiki, Miki Aihara, Keisuke Nagano, Koji Ohmoto, Yoshitaka Yamamura
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 349(2)
Tolvaptan, a selective vasopressin V2 receptor antagonist, slows the increase in total kidney volume and the decline in kidney function in patients with the results of the Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic K
Publikováno v:
The Journal of endocrinology. 206(1)
The effects of stable chronic hyponatremia on the central nervous system are largely unknown, clinically, or in experimental animals. The aim of this study was to identify and characterize these effects in rats. Tolvaptan, a vasopressin V2 receptor a